Purpose: unify patient follow-up tools — you can embed downloadable PDFs or digital forms here.

Validated tools

Tool Use Scoring
EORTC QLQ-C30 Global oncology QoL 30 items → transformed 0–100 (higher = better)
SF-36 General health survey 8 subscales; MCS/PCS summary scores
FACT-P Prostate-specific QoL Physical, social, emotional, functional + prostate subscale
HADS Anxiety/Depression 14 items; ≥ 8 = probable disorder
PHQ-9 Depression severity 9 items; ≥ 10 = moderate depression
IPSS Urinary symptoms (prostate) 0–7 mild, 8–19 moderate, 20–35 severe

Suggested workflow

  1. Baseline: EORTC QLQ-C30 + disease-specific (FACT-P or IPSS).

  2. During therapy: repeat every 6–12 months.

  3. After therapy: once yearly for survivorship monitoring.

  4. Record results in EMR; track trends over time.

Patient engagement tip: share printed scores with patients to visualize progress — it reinforces adherence and shared decision-making.

PreviousNext